Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Teriparatide and osseous regeneration in the oral cavity.

Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK.

N Engl J Med. 2010 Dec 16;363(25):2396-405. doi: 10.1056/NEJMoa1005361. Epub 2010 Oct 16.

2.

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

Brixen KT, Christensen PM, Ejersted C, Langdahl BL.

Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70. Review.

3.

Anabolic therapy for osteoporosis.

Bilezikian JP.

Int J Fertil Womens Med. 2005 Mar-Apr;50(2):53-60. Review.

PMID:
16334411
4.

Guided tissue regeneration for periodontal infra-bony defects.

Needleman IG, Worthington HV, Giedrys-Leeper E, Tucker RJ.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001724. Review.

PMID:
16625546
5.

Teriparatide: a review.

Quattrocchi E, Kourlas H.

Clin Ther. 2004 Jun;26(6):841-54. Review.

PMID:
15262455
6.

Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report.

Wang HL, Weber D, McCauley LK.

J Periodontol. 2007 Mar;78(3):584-94. Review.

PMID:
17335384
7.

Parathyroid hormone as an anabolic skeletal therapy.

Rubin MR, Bilezikian JP.

Drugs. 2005;65(17):2481-98. Review.

PMID:
16296873
8.

[Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].

Tanaka S, Hata K, Yoneda T.

Clin Calcium. 2012 Jan;22(1):75-82. doi: CliCa12017582. Review. Japanese.

PMID:
22201102
9.

A review of teriparatide and its clinical efficacy in the treatment of osteoporosis.

Dobnig H.

Expert Opin Pharmacother. 2004 May;5(5):1153-62. Review.

PMID:
15155114
10.

[Present status of periodontal regeneration - FGF-2 and Teriparatide - ].

Takedachi M, Murakami S.

Clin Calcium. 2012 Jan;22(1):99-104. doi: CliCa120199104. Review. Japanese.

PMID:
22201105
11.

Reduced risk of back pain following teriparatide treatment: a meta-analysis.

Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH.

Osteoporos Int. 2006 Feb;17(2):273-80. Epub 2005 Sep 2. Review.

PMID:
16142502
12.

[Therapeutic agents for disorders of bone and calcium metabolism--Teriparatide, parathyroid hormone (1-34) as a daily subcutaneous injection].

Hashimoto Y, Wakayama N, Miyauchi A.

Clin Calcium. 2007 Jan;17(1):48-55. Review. Japanese.

PMID:
17211093
13.

The use of PTH in the treatment of osteoporosis.

Borba VZ, MaƱas NC.

Arq Bras Endocrinol Metabol. 2010 Mar;54(2):213-9. Review.

14.
15.

Parathyroid hormone and its effects on dental tissues.

Aggarwal P, Zavras A.

Oral Dis. 2012 Jan;18(1):48-54. doi: 10.1111/j.1601-0825.2011.01850.x. Epub 2011 Sep 6. Review.

PMID:
21895887
16.

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review.

Trevisani VF, Riera R, Imoto AM, Saconato H, Atallah AN.

Sao Paulo Med J. 2008 Sep;126(5):279-84. Review.

17.

Anabolic skeletal therapy for osteoporosis.

Girotra M, Rubin MR, Bilezikian JP.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):745-54. Review.

18.

Teriparatide in the treatment of osteoporosis.

Stroup J, Kane MP, Abu-Baker AM.

Am J Health Syst Pharm. 2008 Mar 15;65(6):532-9. doi: 10.2146/ajhp070171. Review.

PMID:
18319498
19.

Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.

Bilezikian JP.

Curr Osteoporos Rep. 2008 Mar;6(1):24-30. Review.

PMID:
18430397
20.

Parathyroid hormone applications in the craniofacial skeleton.

Chan HL, McCauley LK.

J Dent Res. 2013 Jan;92(1):18-25. doi: 10.1177/0022034512464779. Epub 2012 Oct 15. Review.

Items per page

Supplemental Content

Write to the Help Desk